68 related articles for article (PubMed ID: 3255415)
1. Antigen presentation by monocytes of CGD-patients and by phenylbutazone treated monocytes of normal peripheral blood.
Zegers BJ; Marwitz PA; Peeters-Holtrop S; Rijkers GT; van der Meer JW; Heijnen CJ
Acta Paediatr Hung; 1988-1989; 29(1-2):55-7. PubMed ID: 3255415
[No Abstract] [Full Text] [Related]
2. Altered antigen-presentation in the induction of the in-vitro antigen-specific T helper cell function in patients with chronic granulomatous disease.
Heijnen CJ; van der Meer JW; Zegers BJ
Clin Exp Immunol; 1986 Oct; 66(1):111-7. PubMed ID: 2948743
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes.
Katz P; Simone CB; Henkart PA; Fauci AS
J Clin Invest; 1980 Jan; 65(1):55-63. PubMed ID: 6243141
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a nonoxidative mechanism of human natural killer (NK) cell cytotoxicity by using mononuclear effector cells from healthy donors and from patients with chronic granulomatous disease.
Kay HD; Smith DL; Sullivan G; Mandell GL; Donowitz GR
J Immunol; 1983 Oct; 131(4):1784-8. PubMed ID: 6311897
[TBL] [Abstract][Full Text] [Related]
5. Antigens of the Kell blood group system on neutrophils and monocytes: their relation to chronic granulomatous disease.
Marsh WL; Uretsky SC; Douglas SD
J Pediatr; 1975 Dec; 87(6 Pt 2):1117-20. PubMed ID: 52702
[TBL] [Abstract][Full Text] [Related]
6. ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease.
Brown KL; Bylund J; MacDonald KL; Song-Zhao GX; Elliott MR; Falsafi R; Hancock RE; Speert DP
Clin Immunol; 2008 Oct; 129(1):90-102. PubMed ID: 18676204
[TBL] [Abstract][Full Text] [Related]
7. Impaired oxidative burst does not affect human monocyte tumoricidal activity.
Chen AR; Koren HS
J Immunol; 1985 Mar; 134(3):1909-13. PubMed ID: 2981928
[TBL] [Abstract][Full Text] [Related]
8. Human rheumatoid synovial and normal blood dendritic cells as antigen presenting cell--comparison with autologous monocytes.
Waalen K; Førre O; Teigland J; Natvig JB
Clin Exp Immunol; 1987 Oct; 70(1):1-9. PubMed ID: 2826055
[TBL] [Abstract][Full Text] [Related]
9. Endothelial progenitor cells possess monocyte-like antigen-presenting and T-cell-co-stimulatory capacity.
Raemer PC; Haemmerling S; Giese T; Canaday DH; Katus HA; Dengler TJ; Sivanandam VG
Transplantation; 2009 Feb; 87(3):340-9. PubMed ID: 19202438
[TBL] [Abstract][Full Text] [Related]
10. Is the IFN-gamma-induced enhancement of superoxide production in CGD-phagocytes caused by increased expression of the p47-phox cytosolic protein.
Jendrossek V; Damm U; Liese J; Belohradsky BH; Gahr M
Immunodeficiency; 1993; 4(1-4):187-90. PubMed ID: 8167697
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease.
Kawai T; Watanabe N; Yokoyama M; Arai K; Oana S; Harayama S; Yasui K; Oh-Ishi T; Onodera M
Clin Immunol; 2013 May; 147(2):122-8. PubMed ID: 23583898
[TBL] [Abstract][Full Text] [Related]
12. Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease.
Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Ueki Y; Nakao H; Tezuka H; Matsunaga M; Fukuda T; Ishikawa N
Clin Exp Immunol; 1988 Apr; 72(1):84-90. PubMed ID: 3260842
[TBL] [Abstract][Full Text] [Related]
13. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency.
Ruppert J; Friedrichs D; Xu H; Peters JH
Immunobiology; 1991 Aug; 182(5):449-64. PubMed ID: 1717365
[TBL] [Abstract][Full Text] [Related]
14. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
[TBL] [Abstract][Full Text] [Related]
15. Effect of measles virus infection on MHC class II expression and antigen presentation in human monocytes.
Leopardi R; Ilonen J; Mattila L; Salmi AA
Cell Immunol; 1993 Apr; 147(2):388-96. PubMed ID: 7680965
[TBL] [Abstract][Full Text] [Related]
16. Effect of interferon-gamma on antigen processing in human monocytes.
Nadler SG; Rankin BM; Moran-Davis P; Cleaveland JS; Kiener PA
Eur J Immunol; 1994 Dec; 24(12):3124-30. PubMed ID: 7805741
[TBL] [Abstract][Full Text] [Related]
17. Letter: Phagocytosis in chronic granulomatous disease.
Biggar WD
Lancet; 1975 Jul; 2(7923):31-2. PubMed ID: 49623
[No Abstract] [Full Text] [Related]
18. HIV env glycoprotein shares a cross-reacting epitope with a surface protein present on activated human monocytes and involved in antigen presentation.
Beretta A; Grassi F; Pelagi M; Clivio A; Parravicini C; Giovinazzo G; Andronico F; Lopalco L; Verani P; Buttò S
Eur J Immunol; 1987 Dec; 17(12):1793-8. PubMed ID: 2446880
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the relative roles of antigen and nonantigen signals in activation of allogeneic T cells.
Uren S; Boyle W
Transplant Proc; 1989 Oct; 21(5):3753-4. PubMed ID: 2530673
[No Abstract] [Full Text] [Related]
20. [Expression of HLA class II antigens on human monocytes and its relation to antigen-presenting function].
Xiong SQ; Feng XW
Sheng Li Ke Xue Jin Zhan; 1991 Apr; 22(2):159-61. PubMed ID: 1724572
[No Abstract] [Full Text] [Related]
[Next] [New Search]
